Andres Ricaurte-Fajardo, M.D.
Postdoctoral Radiology Fellow
Division of Molecular Imaging and Therapeutics,
Weill Cornell Medicine
Dr. Andres Ricaurte-Fajardo has been a part of our team since 2022. He completed his M.D. at Pontificia Universidad Javeriana in Bogota, Colombia, followed by a postdoctoral fellowship in molecular imaging and therapeutics at Weill Cornell Medicine in New York City. He is currently in his residency in clinical neurology.
Dr. Ricaurte Fajardo’s research interests include stroke, reversible cerebral vasoconstriction syndrome, neurodegenerative diseases, cancer imaging, and health equity. He is also a strong advocate for high-quality medical education. During his time at Weill Cornell, he served as a problem-based learning facilitator for the Essential Principles of Medicine (EPOM) course, where he instructed first-year medical students in fundamental concepts encompassing science, patient care, and physicianship. He fostered an interactive learning environment that encouraged active participation and collaborative problem-solving among students.
He has authored numerous papers on these topics in world-class journals and has presented at some of the most prestigious neurology, radiology, and oncology conferences worldwide. His strong leadership skills are demonstrated through his coordination and improvement of radiotherapeutic care for cancer patients in clinical trials, as well as his involvement in the Weill Cornell Meyer Cancer Center as a member of the Trainee Advisory Council.
In recognition of his impactful contributions to underserved communities, Dr. Ricaurte Fajardo has received more than six honors in recent years, including the 2023 Pioneer in Diversity Louis Wade Sullivan, M.D. Award at Weill Cornell Medicine. Additionally, he received the Ralph Blumhardt Award from the American College of Nuclear Medicine and the Hill Day Travel Award from Weill Cornell Medicine, the American Association of Cancer Research, and the Association of American Cancer Institutes. This prestigious opportunity enabled him to advocate for increased funding for cancer research to the National Cancer Institute in the U.S. Capitol, engaging with congressional teams alongside a select group of cancer experts from leading institutions in the United States.
Currently, he is focused on theranostics, neurodegenerative diseases, and vascular neurology research aimed at reducing healthcare disparities, utilizing his international experience and global perspective to tackle health issues both locally and globally.